Trial Profile
Assessing the Cortical Response to Noxious and Auditory Stimuli Using Near Infrared Spectroscopy in Subjects Under General Anesthesia
Status:
Recruiting
Phase of Trial:
Phase I
Latest Information Update: 05 Jan 2023
Price :
$35
*
At a glance
- Drugs Remifentanil (Primary)
- Indications Anaesthesia; Pain
- Focus Pharmacodynamics
- 01 Apr 2022 Results published in the PLOS Medicine
- 06 Jan 2021 Planned End Date changed from 1 Jan 2021 to 1 Dec 2021.
- 06 Jan 2021 Planned primary completion date changed from 1 Dec 2020 to 1 Dec 2021.